BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27809504)

  • 41. Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma.
    Zhang J; Liu Z; Lian Z; Liao R; Chen Y; Qin Y; Wang J; Jiang Q; Wang X; Gong J
    Sci Rep; 2016 Oct; 6():35784. PubMed ID: 27767105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analgesic and Anticancer Activity of Benzoxazole Clubbed 2-Pyrrolidinones as Novel Inhibitors of Monoacylglycerol Lipase.
    Afzal O; Altamimi ASA; Shahroz MM; Sharma HK; Riadi Y; Hassan MQ
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33924091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
    Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
    Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors.
    Aida J; Fushimi M; Kusumoto T; Sugiyama H; Arimura N; Ikeda S; Sasaki M; Sogabe S; Aoyama K; Koike T
    J Med Chem; 2018 Oct; 61(20):9205-9217. PubMed ID: 30251836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present).
    Bononi G; Poli G; Rizzolio F; Tuccinardi T; Macchia M; Minutolo F; Granchi C
    Expert Opin Ther Pat; 2021 Feb; 31(2):153-168. PubMed ID: 33085920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone.
    Matuszak N; Es Saadi B; Labar G; Marchand-Brynaert J; Lambert DM
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7321-4. PubMed ID: 22056744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.
    Li M; Liu S; Chen H; Zhou X; Zhou J; Zhou S; Yuan H; Xu QL; Liu J; Cheng K; Sun H; Wang Y; Chen C; Wen X
    Eur J Med Chem; 2020 Aug; 199():112279. PubMed ID: 32497973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors.
    Cisneros JA; Björklund E; González-Gil I; Hu Y; Canales A; Medrano FJ; Romero A; Ortega-Gutiérrez S; Fowler CJ; López-Rodríguez ML
    J Med Chem; 2012 Jan; 55(2):824-36. PubMed ID: 22185522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
    Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
    J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer.
    Li X; Gao S; Li W; Liu Z; Shi Z; Qiu C; Jiang J
    J Obstet Gynaecol Res; 2019 Oct; 45(10):2043-2054. PubMed ID: 31357249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase.
    Miceli M; Casati S; Allevi P; Berra S; Ottria R; Rota P; Branchini BR; Ciuffreda P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New diterpenes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL).
    De Leo M; Huallpa CG; Alvarado B; Granchi C; Poli G; De Tommasi N; Braca A
    Fitoterapia; 2018 Oct; 130():251-258. PubMed ID: 30240845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan.
    Chen AL; Lum KM; Lara-Gonzalez P; Ogasawara D; Cognetta AB; To A; Parsons WH; Simon GM; Desai A; Petrascheck M; Bar-Peled L; Cravatt BF
    Nat Chem Biol; 2019 May; 15(5):453-462. PubMed ID: 30911178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives.
    Bononi G; Di Stefano M; Poli G; Ortore G; Meier P; Masetto F; Caligiuri I; Rizzolio F; Macchia M; Chicca A; Avan A; Giovannetti E; Vagaggini C; Brai A; Dreassi E; Valoti M; Minutolo F; Granchi C; Gertsch J; Tuccinardi T
    J Med Chem; 2022 May; 65(10):7118-7140. PubMed ID: 35522977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling.
    Labar G; Bauvois C; Muccioli GG; Wouters J; Lambert DM
    Chembiochem; 2007 Jul; 8(11):1293-7. PubMed ID: 17579916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and characterization of a new fluorogenic substrate for monoacylglycerol lipase and application to inhibition studies.
    Lauria S; Casati S; Ciuffreda P
    Anal Bioanal Chem; 2015 Oct; 407(26):8163-7. PubMed ID: 26329281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.